Delivery Order SPE2DR25D2104-SPE2DR26F3UXF
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order by the Defense Logistics Agency on January 27, 2026, for Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $1,286.98. This is a non-set-aside competitive award with an ultimate completion date of January 28, 2026, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order issued under...
- AmerisourceBergen Drug Corp (child entity of Cencora, Inc.) received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,563.40 for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a completion date of February 3, 2026. The award was made on a fully competitive, non-set-aside basis to support federal medical supply requirements. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, which serves as the corporate headquarters for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens with a ceiling value of $1,397.57. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The prime IDC, valued at up to $999.9 million...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens, valued at $1,312.94. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,943.76 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.52 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ml 3ml insulin pens on January 16, 2026, with a completion date of January 20, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,423.10 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries a completion deadline of January 8, 2026. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- AmerisourceBergen Drug Corp has been awarded a competitively competed delivery order by the Defense Logistics Agency (DLA) for Lantus SoloStar 100 Unit/ML insulin pens, valued at $1,294.28. The order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery requirement from its corporate office location....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,431.23 by the Defense Logistics Agency on January 29, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by January 30, 2026. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $8,990.27 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a completion date of January 8, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...